Toward omitting sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with clinically node-negative breast cancer

CONCLUSION: The probability of nodal positivity after neoadjuvant chemotherapy was less than 3 per cent in patients with TNBC or HER2-positive disease who achieved a breast rCR on MRI. These patients could be included in trials investigating the omission of sentinel node biopsy after neoadjuvant chemotherapy.PMID:34157085 | DOI:10.1002/bjs.12026

Source: The British Journal of Surgery - June 22, 2021 Category: Surgery Authors: M E M van der Noordaa F H van Duijnhoven F N E Cuijpers E van Werkhoven T G Wiersma P H M Elkhuizen G Winter-Warnars V Dezentje G S Sonke E J Groen M Stokkel M T F D Vrancken Peeters Source Type: research